Evidence map›Paper›PMID 35212721›Full record

ArticleInvestigative ophthalmology & visual science2022

Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD.

Yuhua Zhang, SriniVas R Sadda, David Sarraf, Thomas A Swain, Mark E Clark, Kenneth R Sloan, William E Warriner, Cynthia Owsley, Christine A Curcio

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yuhua ZhangDoheny Eye Institute, Los Angeles, California, United States.
SriniVas R SaddaDoheny Eye Institute, Los Angeles, California, United States.
David SarrafDepartment of Ophthalmology, University of California - Los Angeles, Los Angeles, California, United States.
Thomas A SwainDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Mark E ClarkDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Kenneth R SloanDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
William E WarrinerDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Cynthia OwsleyDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Christine A CurcioDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States.
University of Alabama at Birmingham · USUniversity of California, Los Angeles · USDoheny Eye Institute · US

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Oliver W Gramlich · 1985 to 2026
$16.9M
Functionally Validated Structural Endpoints for Early AMDR01EY029595 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURCIO, CHRISTINE A, OWSLEY, CYNTHIA · 2019 to 2023
$4.1M
A hyperspectral approach to RPE fluorophores in AMDR01EY027948 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ACH, THOMAS, CURCIO, CHRISTINE A · 2017 to 2025
$3.8M
VISUAL DYSFUNCTION AND AGING--UNDERLYING MECHANISMSR01AG004212 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OWSLEY, CYNTHIA · 1985 to 2012
$3.7M
In vivo Ultrastructure of Chorioretinal DiseaseR01EY024378 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHANG, YUHUA LIANG · 2015 to 2023
$2.9M
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY024378NEI NIH HHS R01 EY027948NEI NIH HHS R01 EY029595NIA NIH HHS R01 AG004212
6 · The paper itself

Abstract

Purpose: Subretinal drusenoid deposits (SDD) first appear in the rod-rich perifovea and can extend to the cone-rich fovea. To refine the spatial relationship of visual dysfunction with SDD burden, we determined the topography of mesopic and scotopic light sensitivity in participants with non-neovascular AMD with and without SDD. Methods: Thirty-three subjects were classified into three groups: normal (n = 9), AMD-Drusen (with drusen and without SDD; n = 12), and AMD-SDD (predominantly SDD; n = 12). Mesopic and scotopic microperimetry were performed using 68 targets within the Early Treatment Diabetic Retinopathy Study grid, including points at 1.7° from the foveal center (rod:cone ratio, 0.35). Age-adjusted linear regression was used to compare mesopic and scotopic light sensitivities across groups. Results: Across the entire Early Treatment Diabetic Retinopathy Study grid and within individual subfields, the three groups differed significantly for mesopic and scotopic light sensitivities (all P < 0.05). The AMD-SDD group exhibited significantly decreased mesopic and scotopic sensitivity versus both the normal and the AMD-Drusen groups (all P < 0.05), while AMD-Drusen and normal eyes did not significantly differ (all P > 0.05). The lowest relative sensitivities were recorded for scotopic light levels, especially in the central subfield, in the AMD-SDD group. Conclusions: SDD-associated decrements in rod-mediated vision can be detected close to the foveola, and these deficits are proportionately worse than functional loss in the rod-rich perifovea. This finding suggests that factors other than the previously hypothesized direct cytotoxicity to photoreceptors and local transport barrier limitations may negatively impact vision. Larger prospective studies are required to confirm these observations.

Indexed as

AgedAged, 80 and overFemaleHumansLightMacular DegenerationMaleMesopic VisionMiddle AgedMultimodal ImagingNight VisionProspective StudiesRetinal DrusenTomography, Optical CoherenceVision DisordersVisual Acuity

Identifiers

PMID35212721
PMCPMC8883144
OpenAlexW4214489004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.